Caphosol, a therapeutic option in cancer therapy induced mucositis in children.

Caphosol, a therapeutic option in cancer therapy induced mucositis in children. - Caphosol and mucositits.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35477

Enrollment

Registered

2010-05-20

Start date

2009-10-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mucositis denture sore mouth. Stomatitis

Interventions

Mouth rinse.

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Cancer therapy induced mucositis Hospitalization Age 4-18 years

Exclusion criteria

Exclusion criteria: Previous Caphosol use Previous study participation

Design outcomes

Primary

Measure	Time frame
Duration of mucositis.	—

Secondary

Measure	Time frame
Pain.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)